We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Amgen has signed a strategic research partnership with the University of Washington’s Institute for Protein Design (IPD) that will apply IPD’s de novo protein design expertise to biotech drug discovery.